Close

Tag: Coronavirus information (COVID-19)

Evaxion and ExpreS2ion initiate research collaboration on a novel cytomegalovirus (CMV) vaccine candidate

Evaxion Biotech A/S , a clinical-stage biotechnology company specializing in the development of AI-driven immunotherapies,  announces that the Company has signed a Vaccine Discovery...

Pfizer and BioNTech Receive U.S. FDA EUA for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years

Pfizer Inc. and BioNTech SE announced the U.S. FDA granted Emergency Use Authorization (EUA) of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine as the third...

Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that partner, SK bioscience, has received a...

200M COVID Jab Left Over Doses Leads SII Halting Production

As worldwide demand dwindles, around 200 million doses of COVID-19 vaccine are rusting away in the world's largest vaccine manufacturer's warehouses. As per Bloomberg, Serum...

Sanofi Starts Work On €400 Million Smart Space In Singapore

Sanofi's "factory of the future" in Singapore could be operational by the middle of the decade. One of two so-called Evolutive Vaccine Facilities (EVFs)...

Kings College Uses COVID-19 Tech To Treat Heart Attacks

King's College London, a public research university, is using messenger RNA (mRNA) technology to battle the physiological effects of cardiac arrest in the hopes...

Takeda Announces Approval of Nuvaxovid COVID-19 Vaccine for Primary and Booster Immunization in Japan

Takeda announced that it has received manufacturing and marketing approval from the Japan Ministry of Health, Labour and Welfare (MHLW) for Nuvaxovid® Intramuscular Injection...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read